Reply to “Comment on The third-year results of denosumab sequential therapy trial: An extension of a randomized clinical trial”. // Journal of the Formosan Medical Association. – URL: https://www.sciencedirect.com/science/article/pii/S0929664626009836?dgcid=rss_sd_all
Reply to “Comment on The third-year results of denosumab sequential therapy trial: An extension of a randomized clinical trial”. Journal of the Formosan Medical Association. https://www.sciencedirect.com/science/article/pii/S0929664626009836?dgcid=rss_sd_all
“Reply to “Comment on The third-year results of denosumab sequential therapy trial: An extension of a randomized clinical trial”.” Journal of the Formosan Medical Association.
@article{article55844,
title = {Reply to “Comment on The third-year results of denosumab sequential therapy trial: An extension of a randomized clinical trial”},
journal = {Journal of the Formosan Medical Association},
url = {https://www.sciencedirect.com/science/article/pii/S0929664626009836?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...